G Model
CATTOD-10462; No. of Pages9
ARTICLE IN PRESS
M. Li, S. Bernhard / Catalysis Today xxx (2016) xxx–xxx
3
4.9 Hz, 2H), 7.30 (dd, J = 15.2, 1.3 Hz, 2H), 1.59 (s, 2H). 13C NMR
(125 MHz, CDCl3): ı 157.5, 148.7, 139.5, 136.7, 128.5, 127.5, 127.3,
122.8, 19.4. ESI–MS (m/z, 1% trifluoroacetic acid in MeOH): 441.0
(100%, H2bpsa-PhdMe-Na+), 418.9 (57%, H2bpsa-PhdMe).
N,Nꢀ-(naphthalene-2,3-diyl)bis(pyridine-2-sulfonamide)
(H2bpsa-NPTH). Yield: 36.9%, brown crystals. 1H NMR (500 MHz,
CDCl3): ı 10.46 (s, 2H), 8.79 (d, J = 4.9 Hz, 2H), 8.07 (td, J = 7.9,
0.9 Hz, 2H), 8.04 (s, 2H), 7.98 (dt, J = 7.8, 1.7 Hz, 2H), 7.78 (dd, J = 6.2,
3.2 Hz, 2H), 7.58 (ddd, J = 7.6, 4.9, 1.0 Hz, 2H), 7.44 (dd, J = 6.3,
3.2 Hz, 2H). 13C NMR (125 MHz, CDCl3): ı 157.5, 148.8, 139.5,
132.1, 128.3, 127.7, 127.5, 126.7, 126.4, 122.9. ESI–MS (m/z, 1%
trifluoroacetic acid in MeOH): 463.0 (100%, H2bpsa-NPTH-Na+),
441.0 (60%, H2bpsa-NPTH).
129.4, 129.3, 125.8, 125.2, 118.3, 18.6, 18.2. ESI–MS (m/z, MeOH):
679.0 (100%, [Ir(bpsa-PhdMe)Cl2]−).
Iridium
N,Nꢀ-(naphthalene-2,3-diyl)bis(pyridine-2-
sulfonamide) dichloride sodium salt (Na[Ir(bpsa-NPTH)Cl2])
5. Yield: 32.4%, yellow powder. 1H NMR (500 MHz, CD3CN): ı 9.78
(dd, J = 5.7, 1.5 Hz, 1H), 8.27 (dt, J = 7.8, 1.4 Hz, 1H), 7.93 (m, 3H),
7.86 (ddd, J = 7.7, 5.7, 1.4 Hz, 1H), 7.74 (m, 2H), 7.72 (s, 1H), 7.69
(s, 1H), 7.63 (d, J = 8.2, 1H), 7.33 (m, 2H), 7.25 (ddd, J = 8.1, 6.9,
1.2 Hz, 1H). 13C NMR (125 MHz, D2O): ı 162.1, 158.5, 150.9, 150.7,
145.0, 142.2, 141.4, 139.7, 131.4, 130.6, 129.5, 129.1, 127.2, 126.3,
126.2, 126.1, 126.0, 124.9, 124.7, 113.2. ESI–MS (m/z, MeOH): 701.0
(100%, [Ir(bpsa-NPTH)Cl2]−).
2.3. Methods and techniques
2.2.3. Synthesis of iridium(III) bis(pyridine-2-sulfonamide) (bpsa)
complexes
2.3.1. Physical characterization
1H and 13C NMR spectra were recorded on Bruker Avance
500 MHz spectrometers at room temperature. ESI–MS was per-
formed on Thermo-Fisher LCQ instrument with ∼90 M methanol
solutions. 1% Trifluoroacetic acid was added for mass spectrome-
try of the ligands. Elemental analysis was conducted by Robertson
Microlit Laboratories (Ledgewood, NJ).
Ir(III) bpsa complexes were synthesized by modifying the pre-
viously published procedure [49]. Typically, IrCl3·xH2O (0.10 g,
0.28 mmol), 1 equiv of appropriate H2bpsa ligand (0.28 mmol), and
8/1 (v/v) 2-methoxyethanol/water (∼27 mL) were combined in a
sealed round-bottom flask and degassed with argon for 15 min. The
mixture was heated at 110 ◦C in the dark under an argon atmo-
sphere for 2 h, and the solvent was removed in a rotary evaporator
after the reaction mixture was cooled to room temperature. The
desired Ir(III) bpsa complex was purified by chromatography on
silica gel using 2/1 (v/v) ethyl acetate/acetone eluent, yielding a
yellow powder after drying in the vacuum oven.
2.3.2. Electrochemstry
Cyclic voltammograms were measured on a CH-Instruments
Model 600C Electrochemical Analyzer using
a glassy-carbon
working electrode, a coiled-platinum counter electrode, and a
silver-wire pseudoreference electrode. Solutions were prepared
with 0.1 M tetrabutylammonium hexafluorophosphate (Fluka,
electrochemical grade) as the supporting electrolyte for analysis
in acetonitrile and ∼2 mM corresponding Ir(III) bpsa complex. All
solutions were purged with argon before taking each measurement.
Ferrocene was added as an internal standard, and the oxidation
half-wave potential of ferrocene standard was set to +0.40 V versus
SCE. A scan rate of 0.1 V/s was used, starting from the positive scan
unless further noted.
Iridium N,Nꢀ-(phenylene-1,2-diyl)bis(pyridine-2-sulfonamide)
dichloride sodium salt (Na[Ir(bpsa-Ph)Cl2]) 1. Yield: 35.3%, yellow
powder. 1H NMR (500 MHz, acetone-d6): ı 9.70 (dd, J = 6.3, 1.5 Hz,
1H), 8.40 (dt, J = 7.9, 1.5 Hz, 1H), 8.05 (m, 2H), 7.92 (m, 2H), 7.77
(d, J = 7.9 Hz, 1H), 7.51 (dd, J = 8.0, 1.4 Hz, 1H), 7.45 (ddd, J = 7.6,
6.0, 1.5 Hz, 1H), 7.27 (dd, J = 8.0, 1.3 Hz, 1H), 6.79 (dt, J = 7.8, 1.5 Hz,
1H), 6.67 (dt, J = 7.8, 1.5 Hz, 1H). 13C NMR (125 MHz, D2O): ı 162.3,
161.4, 150.9, 150.8, 142.2, 141.5, 140.4, 130.6, 129.5, 128.9, 125.9,
125.7, 125.2, 122.0, 117.1, 97.3. ESI–MS (m/z, MeOH): 650.1 (100%,
[Ir(bpsa-Ph)Cl2]−).
2.3.3. Dynamic oxygen evolution measurements
Iridium N,Nꢀ-(4,5-dichloro-phenylene-1,2-diyl)bis(pyridine-2-
sulfonamide) dichloride sodium salt (Na[Ir(bpsa-PhdCl)Cl2]) 2.
Yield: 29.7%, dark yellow powder. 1H NMR (500 MHz, CD3CN): ı
9.73 (dd, J = 5.6, 1.2 Hz, 1H), 8.26 (dt, J = 7.9, 1.4 Hz, 1H), 7.97 (dt,
J = 7.7, 1.2 Hz, 1H), 7.90 (m, 2H), 7.85 (ddd, J = 7.8, 5.7, 1.4 Hz, 1H),
7.78 (d, J = 7.8 Hz, 1H), 7.46 (s, 1H), 7.42 (s, 1H), 7.35 (ddd, J = 13.4,
7.7, 1.4 Hz, 1H). 13C NMR (125 MHz, D2O): ı 161.7, 158.1, 151.1,
150.9, 144.6, 142.4, 141.6, 140.6, 130.6, 129.6, 128.9, 127.4, 125.9,
125.2, 123.4, 117.7. ESI–MS (m/z, MeOH): 720.9 (100%, [Ir(bpsa-
PhdCl)Cl2]−).
Typically, a solution of the iridium complex (1 mL) was injected
into a sealed 40 mL EPA vial containing 10 mL of 0.36 M CAN solu-
tion buffered in 1 M HNO3 that was degassed by argon. O2 evolution
was dynamically monitored with pressure transducer equipped on
top of the sealed EPA vials as described in previous literature [42],
and the end point of the reaction was verified by GC analysis.
For water oxidation experiments using sodium periodate
(NaIO4) as a sacrificial oxidant, 30 mL 19 mM unbuffered solution
of the oxidant was placed in a sealed 40 mL EPA vial. A solution
of the iridium complex (1 mL) was then injected into the EPA vial,
and the reaction was monitored immediately after the addition of
the catalyst. Similarly, the components of the headspace in each
reaction vial were checked with GC at the end of the experiments.
Iridium N,Nꢀ-(4,5-difluoro-phenylene-1,2-diyl)bis(pyridine-2-
sulfonamide) dichloride sodium salt (Na[Ir(bpsa-PhdF)Cl2]) 3.
Yield: 27.7%, dark yellow powder. 1H NMR (500 MHz, CD3CN):
ı 9.73 (dd, J = 5.7, 1.0 Hz, 1H), 8.26 (dt, J = 7.8, 1.4 Hz, 1H), 7.96
(dt, J = 7.8, 1.2 Hz, 1H), 7.90 (m, 2H), 7.84 (ddd, J = 7.7, 5.7, 1.4 Hz,
1H), 7.76 (d, J = 7.9 Hz, 1H), 7.34 (ddd, J = 7.6, 5.8, 1.4 Hz, 1H), 7.27
(dd, J = 12.2, 8.0 Hz, 1H), 7.23 (dd, J = 12.3, 8.4 Hz, 1H). 13C NMR
(125 MHz, D2O): ı 161.7, 158.1, 151.2, 151.0, 142.3, 141.6, 130.6,
129.6, 125.8, 125.2, 116.4, 116.2, 105.1, 104.9. ESI–MS (m/z, MeOH):
687.0 (100%, [Ir(bpsa-PhdF)Cl2]−).
2.3.4. DFT calculations
All DFT calculations were performed with Gaussian 09 using the
B3LYP functional and LANL2DZ as the basis set. Default parameters
and thresholds were used for gradient convergence. Geometry opti-
mizations for all five Ir(III) bpsa complexes were carried out under
no constraints in vacuum condition, yielding reasonable optimal
coordinates and orbital energies.
Iridium N,Nꢀ-(4,5-dimethyl-phenylene-1,2-diyl)bis(pyridine-2-
sulfonamide) dichloride sodium salt (Na[Ir(bpsa-PhdMe)Cl2]) 4.
Yield: 34.3%, yellow powder. 1H NMR (500 MHz, CD3CN): ı 9.72
(dd, J = 5.7, 1.5 Hz, 1H), 8.24 (dt, J = 7.8, 1.5 Hz, 1H), 7.92 (dt, J = 7.7,
1.4 Hz, 1H), 7.88 (ddd, J = 7.9, 1.4, 0.6 Hz, 1H), 7.82 (m, 2H), 7.72 (d,
J = 7.9 Hz, 1H), 7.31 (ddd, J = 7.6, 5.8, 1.5 Hz, 1H), 7.20 (s, 1H), 7.08
(s, 1H), 2.21 (s, 3H), 2.14 (s, 1H). 13C NMR (125 MHz, D2O): ı 162.3,
158.6, 150.8, 150.7, 142.1, 142.0, 141.3, 137.8, 134.4, 130.6, 130.4,
3. Results and discussion
3.1. Catalytic activities
The structurally altered derivatives 2–5 as well as the parent
complex 1 were explored side by side for catalytic water oxi-
Please cite this article in press as: M. Li, S. Bernhard, Synthetically tunable iridium(III) bis-pyridine-2-sulfonamide complexes as efficient